• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 3 Star

Last Price$93.22Day Change (%)-0.97%
Open Price$94.50Day Change ($)-0.91
Day Range93.05–94.5152-Week Range72.77–95.50

As of Thu 10/02/2014 06:20 AM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment

    Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment

  2. Research and Markets: Global Antibiotics Market 2014-2018: AstraZeneca, Eli Lilly, GSK, Johnson & Johnson, Novartis , Pfizer & Sanofi Lead the Market

    Research and Markets: Global Antibiotics Market 2014-2018: AstraZeneca, Eli Lilly, GSK, Johnson & Johnson, Novartis , Pfizer & Sanofi Lead the Market

  3. Blockbusters Differentiate Novartis

    The company's diverse operating divisions and robust pipeline should lead to steady growth.

  4. ADC Therapeutics Expands Team

    ADC Therapeutics Expands Team

  5. CAHG Executive Vice President, Chief Creative Officer Robin Shapiro Promoted to President

    CAHG Executive Vice President, Chief Creative Officer Robin Shapiro Promoted to President

  6. UPDATE: These 10 boring stocks will beat your portfolio

    UPDATE: These 10 boring stocks will beat your portfolio

  7. Germany's Merck to Buy Sigma-Aldrich for $17 Billion--3rd Update

    Germany's Merck to Buy Sigma-Aldrich for $17 Billion--3rd Update

  8. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    Top managers continue to focus on higher-quality dividend-paying stocks in a fully valued market.

  9. Looking for Bubbles Part One: A Statistical Approach

    Novartis NVS announced Friday that it is removing Zelnorm for irritable bowel syndrome from the U.S. market at the request of the Food and Drug Administration. We think Zelnorm could eventually return to pharmacy shelves in the United States, but we have drastically reduced our estimate of sales ...

  10. Research and Markets: Global Cirrhosis Therapeutics Pipeline Review 2014 - 7 Companies & 8 Drug Profiles

    Research and Markets: Global Cirrhosis Therapeutics Pipeline Review 2014 - 7 Companies & 8 Drug Profiles

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.